14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARMP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Armata Pharmaceuticals Inc. stock price on Friday which ended trading at $2.49
(Updated on May 03, 2024)

Sell candidate since Apr 09, 2024 Loss -31.02% PDF

No changes to the price of Armata Pharmaceuticals Inc. stock on the last trading day (Friday, 3rd May 2024). During the last trading day the stock fluctuated 10.66% from a day low at $2.44 to a day high of $2.70. The price has fallen in 5 of the last 10 days and is down by -6.57% for this period.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.37 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -20.06% during the next 3 months and, with a 90% probability hold a price between $1.89 and $3.03 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARMP Signals & Forecast

There are mixed signals in the stock today. The Armata Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.55 and $3.24. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, May 01, 2024, and so far it has risen 3.75%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Armata Pharmaceuticals Inc. stock

Armata Pharmaceuticals Inc. finds support from accumulated volume at $2.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.260 between high and low, or 10.66%. For the last week the stock has had daily average volatility of 14.60%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARMP) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Armata Pharmaceuticals Inc. to open at $2.54, and during the day (based on 14 day Average True Range), to move between $2.20 and $2.78, which gives a possible trading interval of +/-$0.292 (+/-11.73%) up or down from last closing price. If Armata Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 23.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.50 (0.40%) than the support at $2.40 (3.61%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Armata Pharmaceuticals Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.280. We will update the financials statements for Armata Pharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 14.12% in the first trading day after earnings release.

Is Armata Pharmaceuticals Inc. stock A Buy?

Armata Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.990 Sell Candidate Unchanged

Predicted Opening Price for Armata Pharmaceuticals Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$2.54 ( 2.14%) $2.49

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARMP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.80 12.58 %
R2 2.70 8.59 %
R1 2.64 6.13 %
Current price: 2.49
Support S1 2.44 -1.85 %
S2 2.38 -4.31 %
S3 2.28 -8.30 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.94 18.07 %
R2 2.55 2.41 %
R1 2.50 0.402 %
Current price 2.49
Support S1 2.40 -3.61%
S2 0 .
S3 0 .

FAQ

What is the symbol for Armata Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Armata Pharmaceuticals Inc. is ARMP and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Armata Pharmaceuticals Inc. Stock?
Armata Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Armata Pharmaceuticals Inc. Stock?
Armata Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Armata Pharmaceuticals Inc. Stock.

What's the current price of Armata Pharmaceuticals Inc. Stock?
As of the end of day on the May 03, 2024, the price of an Armata Pharmaceuticals Inc. (ARMP) share was $2.49.

What is the 52-week high and low for Armata Pharmaceuticals Inc. Stock?
The 52-week high for Armata Pharmaceuticals Inc. Stock is $5.26 and the 52-week low is $1.07.

What is the market capitalization of Armata Pharmaceuticals Inc. Stock?
As of the May 03, 2024, the market capitalization of Armata Pharmaceuticals Inc. is 90.01M.

When is the next earnings date for Armata Pharmaceuticals Inc.?
The upcoming earnings date for Armata Pharmaceuticals Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Armata Pharmaceuticals Inc.

Armata Pharmaceuticals. Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It h... ARMP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT